ApprovedApproved dual agonist

Tirzepatide

Brand examples:MounjaroZepbound

Class: Approved dual agonist
Route: SC injection
Frequency: Once weekly
GLP-1 relevance: Yes

How it works

Dual GIP/GLP-1 receptor agonist 📃

Approved & studied uses

Type 2 diabetes; chronic weight management; OSA/other indications vary by region and label

Regulatory status

Approved (brand products; country-specific)

Safety notes

Prescription-only. Titration is set by your prescriber; Peptimize does not recommend or adjust a schedule.

Key research

SURMOUNT-1trial-registry

Sources

Mounjaro FDA label
Zepbound FDA label

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.